How to Buy Mirum Pharmaceuticals Stock
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
Mirum Pharmaceuticals stock last closed at $67.93, up 4.78% from the previous day, and has increased 63.57% in one year. It has overperformed other stocks in the Biotechnology industry by 1.28 percentage points. Mirum Pharmaceuticals stock is currently +84.3% from its 52-week low of $36.86, and -1.55% from its 52-week high of $69.00.
As of Aug 15, 2025, there are 50.24M shares of MIRM outstanding. The market cap of MIRM is $3.41B. In the past 24 hours, 1.03M MIRM shares were traded.
How to Buy Mirum Pharmaceuticals Stock
Wondering how to invest in Mirum Pharmaceuticals stock? Here's how.
- Figure out where to buy Mirum Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Mirum Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Select your method of payment and add your details.
- Evaluate Mirum Pharmaceuticals stock: The Mirum Pharmaceuticals ticker symbol is MIRM. Is Mirum Pharmaceuticals stock a good investment? Should you buy shares of MIRM? How do MIRM's underlying business fundamentals look? Do top analysts think Mirum Pharmaceuticals is a good buy? Why has MIRM's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if MIRM is a good stock to buy).
- Execute your MIRM trade: Decide if you will purchase MIRM shares at the current market price or use a limit order to purchase MIRM shares at a specific price.
- Monitor your MIRM investment: Create a watchlist to keep tabs on your position in Mirum Pharmaceuticals shares.
Step 1: Figure out where to buy Mirum Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy MIRM shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you are able to invest in MIRM stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on investing apps, you need to deposit funds:
Check out the video below for more details transferring money into your new brokerage account.
Step 4: Evaluate Mirum Pharmaceuticals stock
Once you have figured out the best place to buy Mirum Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Mirum Pharmaceuticals quick stats
Mirum Pharmaceuticals Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on MIRM's stock page.
Is MIRM stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge MIRM's true value.
Using relative valuations methods:
- MIRM could be overvalued based on its P/B ratio of 13.37x, relative to Biotechnology industry P/B ratio of 4.5x
You can do additional valuation analysis on MIRM's stock here.
MIRM Financial Overview
Positive Financial Indicators:
- MIRM profit margin has gone up from -41.3% to -13.6% in the past year.
- There are more short-term assets than long-term liabilities on the MIRM balance sheet.
- There are more short-term assets than short-term liabilities on the MIRM balance sheet.
Negative Financial Indicators:
- MIRM earnings of -$43.01M is not enough to cover its interest payments.
- MIRM's operating cash flow of $9.00M allows it to safely service it's debt of $316.82M.
- MIRM has a relatively high debt to equity ratio of 1.85.
- Total MIRM debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy MIRM stock, according to analysts?
Out of 7 Wall Street analysts who research MIRM, the consensus analyst rating on MIRM is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest MIRM Analyst Recommendations
Ed Arce, a top 2% analyst from HC Wainwright & Co. maintains MIRM with a buy rating and raises their MIRM price target from $66.00 to $72.00, on Feb 28, 2025.
Brian Skorney, a top 27% analyst from Baird maintains MIRM with a buy rating and raises their MIRM price target from $50.00 to $55.00, on Feb 27, 2025.
You can dig deeper into what analysts are projecting on the Mirum Pharmaceuticals stock forecast page.
MIRM Trading Indicators
MIRM Growth Metrics
Last year, MIRM revenue was $429.16M. In the past four year, MIRM's revenue has increased by 149.92% per year. This was faster than the Biotechnology industry average of 63.27%.
Dig into MIRM's earnings and revenue performance here.
What are MIRM insiders up to?
Over the past year, insiders at MIRM have sold more shares than they have bought.
Eric Bjerkholt, CHIEF FINANCIAL OFFICER of MIRM, was the latest MIRM insider to buy. They bought $78,251.46 worth of MIRM stock on Aug 12, 2025.
Learn more about who owns MIRM shares here.
Can I get consistent income from MIRM stock?
No, Mirum Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about MIRM?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your MIRM trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you need additional help with investing in stocks on eToro, click the how to video below:
Step 6: Monitor your MIRM investment
Now that you own some shares in MIRM, you'll want to stay up-to-date on your investment.
Make a watchlist to track the most important metrics related to your MIRM stock.
MIRM Feed
How to Buy Stock in Mirum Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Mirum Pharmaceuticals stock right now:
- Figure out where to buy Mirum Pharmaceuticals stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Mirum Pharmaceuticals stock
- Execute your MIRM trade
- Monitor your MIRM investment
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Mirum Pharmaceuticals, create a watchlist on WallStreetZen today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.